Skip to main content

People in the News: Sep 16, 2010


WaferGen Biosystems this week said that it has appointed Donald Huffman as its new chief financial officer.

Huffman was most recently CFO at Asante Solutions, a medical device company developing a drug-delivery pump. Prior to that, he was CFO at Guava Technologies, EndoSonics, Microcide Pharmaceuticals, Celtrix Pharmaceuticals, and Sanderling Ventures, a biomedical venture capital firm.

Hugh Douglas has joined BioCision as chief operating officer.

Douglas most recently led Bridge4Bio, a global business consulting group. Previously, he was managing director and president of Hoefer, a part of Harvard Bioscience. Douglas was also vice president of the West Coast operations for Amersham Biosciences, now a part of GE Healthcare.

The company has also expanded its corporate advisory board. New members include Lori Kunkel, who has served as chief medical officer at Proteolix/Onyx Pharmaceuticals, vice president of clinical development at Xenocor, and has held other senior positions at Genentech, Chiron, and Genitope; and Paul Nowak, currently CEO of Biotix Holdings and previously CEO and president of VWR International.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.